ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
University of British Columbia
Vancouver, CanadáUniversity of British Columbia-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2023
2015
-
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): Overall survival results of a phase 3 randomised trial
The Lancet Oncology, Vol. 16, Núm. 8, pp. 928-936
2013
-
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: Quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
The Lancet Oncology, Vol. 14, Núm. 3, pp. 236-243
2011
-
A phase 3 trial of bevacizumab in ovarian cancer
New England Journal of Medicine, Vol. 365, Núm. 26, pp. 2484-2496
2010
-
Advanced ovarian cancer: Phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel
Journal of the National Cancer Institute, Vol. 102, Núm. 20, pp. 1547-1556